using a healthy canine model , we evaluated the influence of renal physiological activity on the stability , intrarenal distribution , and clearance of aztreonam and compared the results with the concentrations of aztreonam that can be achieved in the scarred devitalized renal tissues of patients with end-stage kidney disease .
C0022646
renal
C0022661
end-stage